ATE259800T1 - Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate - Google Patents
Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivateInfo
- Publication number
- ATE259800T1 ATE259800T1 AT99900338T AT99900338T ATE259800T1 AT E259800 T1 ATE259800 T1 AT E259800T1 AT 99900338 T AT99900338 T AT 99900338T AT 99900338 T AT99900338 T AT 99900338T AT E259800 T1 ATE259800 T1 AT E259800T1
- Authority
- AT
- Austria
- Prior art keywords
- cyclopentenopyridine
- benzodioxol
- derivatives
- substituted
- group
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2397998 | 1998-01-21 | ||
| PCT/JP1999/000131 WO1999037639A1 (en) | 1998-01-21 | 1999-01-18 | Substituted 5-(2,2-difluoro-1,3-benzodioxol-5-yl) cyclopentenopyridine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE259800T1 true ATE259800T1 (de) | 2004-03-15 |
Family
ID=12125689
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99900338T ATE259800T1 (de) | 1998-01-21 | 1999-01-18 | Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6413979B1 (de) |
| EP (1) | EP1049691B1 (de) |
| JP (1) | JP4432261B2 (de) |
| AT (1) | ATE259800T1 (de) |
| AU (1) | AU742423B2 (de) |
| CA (1) | CA2318184C (de) |
| DE (1) | DE69914880T2 (de) |
| ES (1) | ES2216482T3 (de) |
| WO (1) | WO1999037639A1 (de) |
| ZA (1) | ZA99440B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2742261T3 (es) * | 2011-04-15 | 2020-02-13 | Hivih | Inhibidores de la replicación viral, su proceso de preparación y sus usos terapéuticos |
| MX2013015058A (es) | 2011-06-24 | 2014-01-20 | Amgen Inc | Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos. |
| CN103906733A (zh) | 2011-06-24 | 2014-07-02 | 安姆根有限公司 | Trpm8拮抗剂及其在治疗中的用途 |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| EP2821104A1 (de) | 2013-07-05 | 2015-01-07 | Laboratoire Biodim | Inhibitoren der Virenreplikation, Verfahren zu deren Herstellung und deren therapeutische Verwendung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0612244T3 (da) * | 1991-11-05 | 2002-01-14 | Smithkline Beecham Corp | Endothelinreceptorantagonister |
| US5714479A (en) | 1993-08-18 | 1998-02-03 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| US5389620A (en) | 1993-08-18 | 1995-02-14 | Banyu Pharmaceutical Co., Ltd. | Endothelin antagonistic heteroaromatic ring-fused cyclopentene derivatives |
| EP0714897B1 (de) * | 1993-08-18 | 2001-02-14 | Banyu Pharmaceutical Co., Ltd. | Kondensierte heteroaromatische cyclopentenderivate mit endothelin-antagonistischer aktivität |
| CZ296098A3 (cs) | 1996-04-04 | 1999-06-16 | Banyu Pharmaceutical Co., Ltd. | Způsob léčby srdečního selhání antagonisty endothelinu |
| EP0923557A4 (de) * | 1996-08-09 | 1999-12-08 | Merck & Co Inc | Stereoselektive deoxygenierungsreaktion |
-
1999
- 1999-01-18 EP EP99900338A patent/EP1049691B1/de not_active Expired - Lifetime
- 1999-01-18 CA CA002318184A patent/CA2318184C/en not_active Expired - Fee Related
- 1999-01-18 AT AT99900338T patent/ATE259800T1/de not_active IP Right Cessation
- 1999-01-18 DE DE69914880T patent/DE69914880T2/de not_active Expired - Lifetime
- 1999-01-18 AU AU18907/99A patent/AU742423B2/en not_active Ceased
- 1999-01-18 ES ES99900338T patent/ES2216482T3/es not_active Expired - Lifetime
- 1999-01-18 WO PCT/JP1999/000131 patent/WO1999037639A1/en active IP Right Grant
- 1999-01-18 US US09/582,225 patent/US6413979B1/en not_active Expired - Fee Related
- 1999-01-18 JP JP2000528561A patent/JP4432261B2/ja not_active Expired - Fee Related
- 1999-01-21 ZA ZA9900440A patent/ZA99440B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DE69914880D1 (de) | 2004-03-25 |
| CA2318184A1 (en) | 1999-07-29 |
| DE69914880T2 (de) | 2004-08-05 |
| JP4432261B2 (ja) | 2010-03-17 |
| EP1049691B1 (de) | 2004-02-18 |
| AU1890799A (en) | 1999-08-09 |
| AU742423B2 (en) | 2002-01-03 |
| ZA99440B (en) | 1999-07-21 |
| ES2216482T3 (es) | 2004-10-16 |
| JP2002501064A (ja) | 2002-01-15 |
| WO1999037639A1 (en) | 1999-07-29 |
| US6413979B1 (en) | 2002-07-02 |
| EP1049691A1 (de) | 2000-11-08 |
| CA2318184C (en) | 2008-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
| LTPA2016013I1 (lt) | 2-okso-1-pirolidino dariniai, jų gamybos būdas ir jų panaudojimas | |
| RS51444B (sr) | JEDINJENJA KOJA SADRŽE LAKTAM I NJIHOVI DERIVATI KAO INHIBITORI FAKTORA Xa | |
| YU69902A (sh) | Novi derivati piperazina | |
| NO982606D0 (no) | Naftylsubstituerte benzimidazolderivater som antikoagulanter | |
| DE69830504D1 (de) | Antithrombotische mitteln | |
| TR200200579T2 (tr) | Amino-tirazolpiridin türevleri. | |
| DE69831868D1 (en) | Antithrombosemittel | |
| ES2013801A6 (es) | Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales. | |
| DE69705829D1 (de) | Meta-substituierte phenylsulphonamidderivate | |
| MXPA02003977A (es) | Inhibidores de adhesion de celula mediada por al°2. | |
| DE50005437D1 (en) | Substituierte thien-3-yl-sulfonylamino(thio)carbonyl-triazolin(thi)one | |
| YU30603A (sh) | Derivati premošćenog piperazina | |
| CA2037975A1 (en) | 5-hydroxy-2,3-dihydrobenzofuran analogs as leukotriene biosynthesis inhibitors | |
| BG104447A (en) | Biphenylamidine derivatives | |
| DE60114640D1 (en) | Antithrombosemittel | |
| ATE259800T1 (de) | Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate | |
| ATE200291T1 (de) | Cephemderivate | |
| HUP0104213A2 (hu) | Vankoreszmicin, eljárás előállítására és gyógyszerként történő alkalmazása | |
| AU6191599A (en) | Method for preparing trion-bis(oxime ether) derivatives andrion-mono and trion-bis(oxime ether) derivatives obtained therewith | |
| MXPA03003466A (es) | Derivados de piranosido. | |
| DE69528984D1 (de) | Hemmung der leukotrienbiosynthese mittels harnstoffderivaten | |
| MEP28508A (en) | Amycomycin, a process for its production and its use as a pharmaceutical |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |